Three Reasons to Retain Merit Medical (MMSI) Stock for Now
https://www.zacks.com/stock/news/2277491/three-reasons-to-retain-merit-medical-mmsi-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2277491
May 22, 2024 - Merit Medical's (MMSI) strong product portfolio raises optimism about the stock.
0
AngioDynamics' (ANGO) AlphaVac System Gets CE Mark Approval
https://www.zacks.com/stock/news/2277490/angiodynamics-ango-alphavac-system-gets-ce-mark-approval?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2277490
May 22, 2024 - AngioDynamics (ANGO) announces the European CE Mark approval of its AlphaVac F1885 System, which is likely to expand the range of therapy alternatives available to pulmonary embolism patients.
0
Southern Copper (SCCO) to Gain From Higher Production & Prices
https://www.zacks.com/stock/news/2277528/southern-copper-scco-to-gain-from-higher-production-prices?cid=CS-ZC-FT-analyst_blog|zer_report_update-2277528
May 22, 2024 - Southern Copper (SCCO) is poised to grow on the back of its existing copper reserves, solid growth projects and recent pickup in copper prices.
0
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
https://www.zacks.com/stock/news/2276844/three-reasons-to-retain-inspire-medical-insp-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2276844
May 21, 2024 - Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
0
Philips' (PHG) Reports Positive AI-Powered Cardiac Study Data
https://www.zacks.com/stock/news/2276279/philips-phg-reports-positive-ai-powered-cardiac-study-data?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2276279
May 20, 2024 - Philips' (PHG) AI-powered cardiac monitoring solutions demonstrate significantly lower re-admissions and a higher rate of survival in the retrospective study evaluating it in stroke patients.
0
Masimo's (MASI) New Offering to Serve Personalized Audio Market
https://www.zacks.com/stock/news/2276280/masimo-s-masi-new-offering-to-serve-personalized-audio-market?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2276280
May 20, 2024 - Masimo's (MASI) new product offering is expected to enable it to expand its footprint in the personalized hearables market by offering personalized listening experiences.
0
Veeva's (VEEV) Vault Basics to Boost Efficiency for Biotechs
https://www.zacks.com/stock/news/2275655/veeva-s-veev-vault-basics-to-boost-efficiency-for-biotechs?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2275655
May 17, 2024 - Veeva (VEEV) announces the availability of Vault Basics for biotechs, which aims to deliver complete and pre-validated solutions for expanding businesses.
0
AxoGen (AXGN) Initiates BLA Submission for Avance Nerve Graft
https://www.zacks.com/stock/news/2275648/axogen-axgn-initiates-bla-submission-for-avance-nerve-graft?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2275648
May 17, 2024 - AxoGen (AXGN) starts the process of BLA submission to the FDA for the approval of its Avance Nerve Graft.
0
Three Reasons to Retain AMN Healthcare (AMN) Stock for Now
https://www.zacks.com/stock/news/2275051/three-reasons-to-retain-amn-healthcare-amn-stock-for-now?cid=CS-ZC-FT-analyst_blog|rank_focused-2275051
May 16, 2024 - Investors remain optimistic about AMN Healthcare's (AMN) broad array of services.
0
Merit Medical (MMSI) to Expand Product Suite Via New Launch
https://www.zacks.com/stock/news/2274363/merit-medical-mmsi-to-expand-product-suite-via-new-launch?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2274363
May 15, 2024 - Merit Medical's (MMSI) latest additions to its embolotherapy portfolio are likely to improve the patient experience.
0